Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
Francesco Antonio Veneziano, Cardiologist at ULSS 8 Berica Local Health Authority, shared on LinkedIn:
”CALL FOR PAPERS – Advances in Thrombosis and Antithrombotic Therapy (JCDD MDPI)
Managing thrombosis in daily clinical practice is becoming increasingly complex.
From acute coronary syndromes to high-risk patients with multiple comorbidities, we are constantly balancing ischemic and bleeding risks, often with limited precision.
This Special Issue aims to bring together clinically meaningful and innovative contributions to improve how we:
- Stratify thrombotic risk
- Integrate biomarkers, imaging, and AI
- Tailor antithrombotic therapy in complex settings
We are currently inviting:
- Original research
- Review articles
- Perspectives
Submission deadline: 30 November 2026
If you are working on these topics, feel free to reach out – happy to discuss ideas or potential contributions.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC